These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 25154420)

  • 1. Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
    Obertová Z; Scott N; Brown C; Hodgson F; Stewart A; Holmes M; Lawrenson R
    BMC Fam Pract; 2014 Aug; 15():145. PubMed ID: 25154420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic and socio-economic disparities in prostate cancer screening: lessons from New Zealand.
    Matti B; Lyndon M; Zargar-Shoshtari K
    BJU Int; 2021 Dec; 128 Suppl 3():11-17. PubMed ID: 32599662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of non-structured PSA testing on prostate cancer-specific mortality on New Zealand Māori men.
    Matti B; Nguyen CH; Lyndon MP; Zargar-Shoshtari K
    World J Urol; 2024 Oct; 42(1):558. PubMed ID: 39361189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Maori and Pacific Islander men present with more advanced prostate cancer than European New Zealand men? An analysis of 486 men undergoing biopsy in Auckland.
    Pokorny MR; Scott DJ
    BJU Int; 2011 Apr; 107 Suppl 3():27-32. PubMed ID: 21492373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rural-Urban Differences in Prostate-Specific Antigen (PSA) Screening and Its Outcomes in New Zealand.
    Obertová Z; Hodgson F; Scott-Jones J; Brown C; Lawrenson R
    J Rural Health; 2016; 32(1):56-62. PubMed ID: 26174590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inequalities between Māori and non-Māori men with prostate cancer in Aotearoa New Zealand.
    Egan R; Lawrenson R; Kidd J; Cassim S; Black S; Blundell R; Bateman J; Broughton JR
    N Z Med J; 2020 Sep; 133(1521):69-76. PubMed ID: 32994638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum prostate-specific antigen levels and public health implications in three New Zealand ethnic groups: European, Maori, and Pacific Island men.
    Gray M; Borman B; Crampton P; Weinstein P; Wright C; Nacey J
    N Z Med J; 2005 Feb; 118(1209):U1295. PubMed ID: 15711628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment modalities for Māori and New Zealand European men with localised prostate cancer.
    Obertová Z; Lawrenson R; Scott N; Holmes M; Brown C; Lao C; Tyrie L; Gilling P
    Int J Clin Oncol; 2015 Aug; 20(4):814-20. PubMed ID: 25557325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival disparities between Māori and non-Māori men with prostate cancer in New Zealand.
    Obertová Z; Scott N; Brown C; Stewart A; Lawrenson R
    BJU Int; 2015 Apr; 115 Suppl 5():24-30. PubMed ID: 25124231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving survival disparities in cervical cancer between Māori and non-Māori women in New Zealand: a national retrospective cohort study.
    McLeod M; Harris R; Purdie G; Cormack D; Robson B; Sykes P; Crengle S; Iupati D; Walker N
    Aust N Z J Public Health; 2010 Apr; 34(2):193-9. PubMed ID: 23331365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
    Kearns JT; Holt SK; Wright JL; Lin DW; Lange PH; Gore JL
    Cancer; 2018 Jul; 124(13):2733-2739. PubMed ID: 29781117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Māori ethnicity misclassification on cervical screening coverage.
    Sandiford P; Salvetto M; Bramley D; Wong S; Johnson L
    N Z Med J; 2013 Apr; 126(1372):55-65. PubMed ID: 23793178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study.
    Hjertholm P; Fenger-Grøn M; Vestergaard M; Christensen MB; Borre M; Møller H; Vedsted P
    Int J Cancer; 2015 Jan; 136(2):435-42. PubMed ID: 24905402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
    Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
    Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient perspective on a first raised PSA test.
    Brown C; Hodgson F; Obertova Z; Holmes M; Lawrenson R
    J Prim Health Care; 2015 Sep; 7(3):213-20. PubMed ID: 26437045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for prostate cancer in New Zealand general practice.
    Zuzana O; Ross L; Fraser H; Charis B; Alistair S; Leanne T; Michael H; Peter G
    J Med Screen; 2013 Mar; 20(1):49-51. PubMed ID: 23612467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The costs of identifying undiagnosed prostate cancer in asymptomatic men in New Zealand general practice.
    Lao C; Brown C; Obertová Z; Edlin R; Rouse P; Hodgson F; Holmes M; Gilling P; Lawrenson R
    Fam Pract; 2013 Dec; 30(6):641-7. PubMed ID: 24055993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
    JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.